Table 1.
total (n = 51) | non-PH (n = 21) | PH (n = 30) | P | |
---|---|---|---|---|
Sex (female) | 39 (76.5%) | 15 (71.4%) | 24 (80%) | 0.518 |
Age (year) | 33 (14–67) | 30 (15–65) | 35.5 (22–67) | 0.196 |
Median duration of disease (months) | 28 (1–540) | 17 (1–120) | 45.5 (1–540) | 0.009* |
Clinical symptoms | ||||
Cough | 34 (66.7%) | 15 (71.4%) | 19 (63.3%) | 0.546 |
Hemoptysis | 24 (47.1%) | 14 (66.7%) | 10 (33.3%) | 0.019* |
Dyspnea | 36 (70.6%) | 11 (52.4%) | 25 (83.3%) | 0.017* |
Chest pain | 23 (45.1%) | 15 (71.4%) | 8 (26.7%) | 0.002* |
Palpitation | 12 (23.5%) | 4 (19.0%) | 8 (26.7%) | 0.767 |
Fever | 22 (43.1%) | 13 (61.9%) | 9 (30.0%) | 0.024* |
Lab tests | ||||
WBC (×109/L) | 9.07 (4.06–18.46) | 9.80 (8.92–17.00) | 8.48 (4.06–18.46) | 0.246 |
ESR (mm/h) | 16 (1–178) | 34 (2–178) | 8.5 (1–140) | 0.027* |
CRP (mg/dL) | 7.17 (0.11–238.31) | 13.7 (0.37–238.31) | 5.65 (0.11–155.00) | 0.284 |
Radiological features | ||||
Cavity | 7 (13.7%) | 5 (23.8%) | 2 (6.7%) | 0.181 |
Nodule | 25 (49.0%) | 11 (52.4%) | 14 (46.7%) | 0.688 |
Pleural thickening | 27 (52.9%) | 10 (47.6%) | 17 (56.7%) | 0.524 |
irregular linear opacities | 26 (51.0%) | 11 (52.4%) | 15 (50.0%) | 0.867 |
Patchy opacities | 27 (52.9%) | 12 (57.1%) | 15 (50.0%) | 0.615 |
Subpleural wedge-shaped shadow | 13 (25.5%) | 10 (42.9%) | 3 (10.0%) | 0.002* |
Mosaic perfusion | 3 (5.9%) | 0 | 3 (10.0%) | 0.259 |
Extrapulmonary vascular involvement | 39 (76.5%) | 13 (61.9%) | 26 (86.7%) | 0.040* |
Aorta | 25 (49.0%) | 8 (38.1%) | 17 (56.7%) | 0.192 |
Carotid artery | 32 (62.7%) | 10 (47.6%) | 22 (73.3%) | 0.062 |
Vertebral artery | 6 (11.8%) | 3 (14.3%) | 3 (10.0%) | 0.979 |
Subclavian artery | 30 (58.8%) | 10 (47.6%) | 20 (66.7%) | 0.174 |
Mesenteric artery | 6 (11.8%) | 0 | 6 (20.0%) | 0.036* |
Renal artery | 18 (35.3%) | 4 (19.0%) | 14 (46.7%) | 0.083 |
Iliac artery | 3 (5.9%) | 1 (4.8%) | 2 (6.7%) | 1.000 |
Coronary artery | 2 (3.9%) | 1 (4.8%) | 1 (3.3%) | 1.000 |
Values in parentheses indicate percentage or range. CRP C-reactive protein, ESR Erythrocyte sedimentation rate, WBC White blood cells. *P < 0.05